In an interview for NBC News, Vin Gupta, MD, MPA, MSc, affiliate assistant professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at…
Dileep R. Yavagal, MD, Professor of Neurology & Neurosurgery and Chief Interventional Neurologist at the University of Miami – Miller School of Medicine, describes a treatment that has…
NEW YORK (Reuters Health) – In the acute treatment of persistent insomnia, cognitive behavioral therapy (CBT) plus zolpidem is more effective than CBT alone, but in the long-term,…
NEW YORK (Reuters Health) – Exercise echocardiography can predict mortality and major cardiac events in patients with known or suspected coronary artery disease, but who have normal exercise…
NEW YORK (Reuters Health) – Carotid artery stenting (CAS) followed immediately by on-pump coronary artery bypass grafting (CABG) is a feasible treatment for high-risk patients who have both…
NEW YORK (Reuters Health) – New research indicates that hyperkyphosis is an independent risk factor for mortality in older women with vertebral fractures. According to the report in…
NEW YORK (Reuters Health) – In cancer patients accidentally overexposed with 5-fluorouracil (5-FU) chemotherapy, the investigational drug vistonuridine (Wellstat Therapeutics Corp) may be lifesaving, according to research to…
NEW YORK (Reuters Health) – Treatment with epinephrine and dexamethasone in the emergency room may help infants with bronchiolitis avoid hospital admission, according to a report in the…
NEW YORK (Reuters Health) – The prevalence of heterotopic ossification in victims of war injuries is roughly 65%, much higher than the rates typically reported with civilian trauma,…
NEW YORK (Reuters Health) – Patients with type 2 diabetes have an almost three-fold higher risk of acute pancreatitis and two-fold greater risk of biliary disease compared with…
NEW YORK (Reuters Health) – The “ABCD” rule for predicting stroke following a first transient ischemic attack (TIA) can be used by emergency physicians to decide which patients…
NEW YORK (Reuters Health) – In women with severe premenstrual syndrome (PMS), sertraline therapy for 4 months rather than for 12 months is associated with a higher relapse…
